Structures by: Cuffini S. L.
Total: 9
C15H14N4O,C7H6O2
C15H14N4O,C7H6O2
CrystEngComm (2020)
a=9.934(2)Å b=8.360(2)Å c=23.571(6)Å
α=90° β=92.977(8)° γ=90°
C15H14N4O,0.5(C7H6O3)
C15H14N4O,0.5(C7H6O3)
CrystEngComm (2020)
a=7.2706(14)Å b=9.5902(19)Å c=11.881(2)Å
α=96.11(3)° β=92.79(3)° γ=98.34(3)°
C15H14N4O,0.5(C7H6O4)
C15H14N4O,0.5(C7H6O4)
CrystEngComm (2020)
a=7.1010(3)Å b=9.4938(4)Å c=12.0005(5)Å
α=95.619(2)° β=92.881(2)° γ=99.035(2)°
Nevirapine butanol 0.3-solvate
C15H14N4O,0.3C4H10O
Acta Crystallographica Section E (2008) 64, 1 o292-o292
a=7.8116(6)Å b=8.4302(7)Å c=12.5451(11)Å
α=84.817(5)° β=88.415(5)° γ=68.252(4)°
Rosiglitazone maleate 0.25-hydrate
C18H20N3O3S,C4H3O4,0.25H2O
Acta Crystallographica Section C (2008) 64, 3 o119-o122
a=9.3145(8)Å b=12.3555(10)Å c=20.8280(17)Å
α=105.475(2)° β=96.330(3)° γ=93.276(2)°
C39H54N6O8S
C39H54N6O8S
Crystal Growth & Design (2015) 15, 11 5233
a=14.633(5)Å b=9.370(5)Å c=15.966(5)Å
α=90.000(5)° β=114.871(5)° γ=90.000(5)°
C38H55BrN6O7
C38H55BrN6O7
Crystal Growth & Design (2015) 15, 11 5233
a=14.3053(7)Å b=9.7478(4)Å c=15.84700(10)Å
α=90° β=111.404(7)° γ=90°
C38H53IN6O6
C38H53IN6O6
Crystal Growth & Design (2015) 15, 11 5233
a=14.3578(7)Å b=9.4796(4)Å c=15.9818(13)Å
α=90° β=111.131(7)° γ=90°
C38H57ClN6O8
C38H57ClN6O8
Crystal Growth & Design (2015) 15, 11 5233
a=14.2750(2)Å b=9.6424(5)Å c=16.008(2)Å
α=90° β=111.617(12)° γ=90°